LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $47,116,000 | -35.5% | 856,658 | -57.4% | 0.27% | -36.3% |
| Q1 2022 | $73,007,000 | -37.1% | 2,008,999 | -19.3% | 0.42% | -25.7% |
| Q4 2021 | $116,012,000 | -2.9% | 2,489,003 | +5.3% | 0.56% | +7.4% |
| Q3 2021 | $119,524,000 | +74.9% | 2,364,003 | +42.0% | 0.52% | +75.0% |
| Q2 2021 | $68,329,000 | +1936.6% | 1,664,534 | +1339.6% | 0.30% | +1900.0% |
| Q1 2021 | $3,355,000 | +3.0% | 115,626 | 0.0% | 0.02% | +25.0% |
| Q4 2020 | $3,256,000 | -17.7% | 115,626 | -9.8% | 0.01% | -25.0% |
| Q3 2020 | $3,958,000 | -31.1% | 128,200 | -5.0% | 0.02% | -36.0% |
| Q2 2020 | $5,746,000 | – | 135,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |